Variant report
Variant | esv15885 |
---|---|
Chromosome Location | chr4:125727333-125730018 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs963915 | chr4:125727347-125727348 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs17008645 | chr4:125727356-125727357 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs532268774 | chr4:125727361-125727362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543923344 | chr4:125727392-125727393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73845302 | chr4:125727406-125727407 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs529837855 | chr4:125727420-125727421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549273623 | chr4:125727441-125727442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190330833 | chr4:125727457-125727458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145761877 | chr4:125727463-125727464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75642836 | chr4:125727477-125727478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552167732 | chr4:125727501-125727502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs963914 | chr4:125727521-125727522 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs7657250 | chr4:125727539-125727540 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs556374593 | chr4:125727558-125727559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79826983 | chr4:125727642-125727643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6814312 | chr4:125727701-125727702 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs77890177 | chr4:125727727-125727728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546493236 | chr4:125727731-125727732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575347965 | chr4:125727753-125727754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558591368 | chr4:125727792-125727793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148966838 | chr4:125727879-125727880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs193184827 | chr4:125727904-125727905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10015945 | chr4:125727923-125727924 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs112891589 | chr4:125727947-125727948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539127989 | chr4:125727982-125727983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs72683849 | chr4:125728042-125728043 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs185162890 | chr4:125728085-125728086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116079097 | chr4:125728087-125728088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114148002 | chr4:125728119-125728120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527602712 | chr4:125728122-125728123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569052969 | chr4:125728129-125728130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143703555 | chr4:125728174-125728175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs147676891 | chr4:125728187-125728188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539998928 | chr4:125728207-125728208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369746078 | chr4:125728211-125728212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564182218 | chr4:125728230-125728231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142332070 | chr4:125728252-125728253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555640196 | chr4:125728253-125728254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201366256 | chr4:125728297-125728298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199541244 | chr4:125728298-125728299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200705910 | chr4:125728300-125728301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550277133 | chr4:125728301-125728302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568449128 | chr4:125728382-125728383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147016520 | chr4:125728408-125728409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148068480 | chr4:125728416-125728417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111761279 | chr4:125728417-125728418 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72396515 | chr4:125728418-125728419 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35347461 | chr4:125728419-125728420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs548034613 | chr4:125728466-125728467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10518443 | chr4:125728477-125728478 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:125724600-125759600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:125726600-125731400 | Weak transcription | Colon Smooth Muscle | Colon |
3 | chr4:125726800-125731200 | Weak transcription | Rectal Smooth Muscle | rectum |
4 | chr4:125727200-125727800 | Enhancers | Brain Germinal Matrix | brain |
5 | chr4:125727600-125727800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr4:125727600-125727800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr4:125728200-125729400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr4:125728400-125729000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr4:125728600-125729400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr4:125728800-125729200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr4:125729000-125729600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr4:125729000-125731600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr4:125729200-125731800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr4:125729400-125729600 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr4:125729400-125731400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
16 | chr4:125729400-125731600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
17 | chr4:125729600-125730800 | Weak transcription | H1 Cell Line | embryonic stem cell |
18 | chr4:125729600-125731800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |